Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a "PET biopsy" method.

Cancer Manag Res · 2019 · PMC6612961 · PMID 31308743

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with one metastatic site were more likely to have a better outcome than those with 2 or more metastatic sites (HR=2.4, 95% CI 0.7–7.3, p =0.13), but this trend did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.